Serial treatment of relapsed/refractory multiple myeloma with different BCMA-targeting therapies
Adam D. Cohen,
Alfred L. Garfall,
Ahmet Dogan,
Simon F. Lacey,
Chris Martin,
Nikoletta Lendvai,
Dan T. Vogl,
Matthew Spear,
Alexander M. Lesokhin
Affiliations
Adam D. Cohen
Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Adam D. Cohen, Abramson Cancer Center, University of Pennsylvania, 3400 Civic Center Blvd, PCAM 12-South, 12-175, Philadelphia, PA 19104
Alfred L. Garfall
Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
Ahmet Dogan
Memorial Sloan Kettering Cancer Center, New York, NY
Simon F. Lacey
Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
Chris Martin
Poseida Therapeutics, San Diego, CA
Nikoletta Lendvai
Memorial Sloan Kettering Cancer Center, New York, NY
Dan T. Vogl
Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
Matthew Spear
Poseida Therapeutics, San Diego, CA
Alexander M. Lesokhin
Memorial Sloan Kettering Cancer Center, New York, NY; Weill-Cornell Medical College, New York, NY
